medline.ch Gastroenterologie Leber Neoplasie

	Predicting treatment response and prognosis of immune checkpoint inhibitors-based combination therapy in advanced hepatocellular carcinoma using a longitudinal CT-based radiomics model: a multicenter study. BMC Cancer Xu J, Li J, Wang T, Luo X, Zhu Z, Wang Y, Wang Y, Zhang Z, Song R, Yang LZ, Wang H, Wong STC, Li H. PMID: 40181337 [PubMed - indexed for MEDLINE]
	Prognostic nutritional index predicts survival in intermediate and advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy combined with PD-(L)1 inhibitors and molecular targeted therapies. BMC Cancer Tang HH, Zhang MQ, Zhang ZC, Fan C, Li SS, Chen W, Wang WD. PMID: 40181323 [PubMed - indexed for MEDLINE]
	A stratified precision screening strategy for enhancing hepatitis B- and C-associated liver cancer detection: a prospective study. Sci Rep He H, Wu Y, Jia Z, Zhang Y, Pan Y, Zhang Y, Su K, Cui Y, Sun Y, Li D, Lv H, Yi J, Wang Y, Kou C, Sun X, Jiang J. PMID: 40181083 [PubMed - indexed for MEDLINE]
	PBK as a novel biomarker performed excellent diagnostic and prognostic value in HCC associated with immune infiltration and methylation. J Mol Histol Lv B, Zhang F, Zhang X, Wang Z, Hao S, Ye N, He N. PMID: 40178670 [PubMed - indexed for MEDLINE]
	Case Report: Successful immune checkpoint inhibitor rechallenge after sintilimab-induced Guillain-BarrÃ© syndrome. Front Immunol Ye L, Yue WR, Shi H, Li JR, Qun YY. PMID: 40176803 [PubMed - indexed for MEDLINE]
	Deep learning-based reconstruction and superresolution for MR-guided thermal ablation of malignant liver lesions. Cancer Imaging Winkelmann MT, Kübler J, Gassenmaier S, Nickel DM, Ashkar A, Nikolaou K, Afat S, Hoffmann R. PMID: 40176185 [PubMed - indexed for MEDLINE]
	Developing a novel predictive model for identifying risk factors associated with being lost to follow-up among high-risk patients for recurrence following radical resection of hepatocellular carcinoma: the first report. BMC Cancer Yu Z, Cao W, Du C, Liu J, Peng L, Wei F. PMID: 40175947 [PubMed - indexed for MEDLINE]
	Low Visceral Adipose Tissue Predicts the Outcome of Neoadjuvant Chemotherapy for Colorectal Liver Metastases: A Multicentre Real-World Study. J Cachexia Sarcopenia Muscle Chen Y, Jia H, Ye R, Zhou Z, Chen W, Zheng M, Zheng Y. PMID: 40170387 [PubMed - indexed for MEDLINE]
	Prognostic value of sarcopenia in patients with unresectable colorectal liver metastases after drug-eluting beads transcatheter arterial chemoembolization: a single center retrospective study. Sci Rep Wang F, Gong B, Chen L, Cao Y, Zhu L, Chai B, Wang J, Zhou G, Zheng C. PMID: 40169848 [PubMed - indexed for MEDLINE]
	Integrating single-cell RNA sequencing, WGCNA, and machine learning to identify key biomarkers in hepatocellular carcinoma. Sci Rep Wang G, Zhang J, Li Y, Zhang Y, Dong W, Wu H, Wang J, Liao P, Yuan Z, Liu T, He W. PMID: 40169794 [PubMed - indexed for MEDLINE]
	Efficacy of radiotherapy combined with targeted therapy and immunotherapy for lymph node metastasis of liver cancer. J Cancer Res Clin Oncol Yan H, Xu J, Li Z, Li N, Guo X, Wu M, Wang D, Lin N, Dong J, Xu X. PMID: 40169437 [PubMed - indexed for MEDLINE]
	Gut microbiota in hepatocellular carcinoma immunotherapy: immune microenvironment remodeling and gut microbiota modification. Gut Microbes Huang M, Ji Q, Huang H, Wang X, Wang L. PMID: 40166981 [PubMed - indexed for MEDLINE]
	Diagnostic model using LI-RADS v2018 for predicting early recurrence of microvascular invasion-negative solitary hepatocellular carcinoma. Cancer Imaging Liang Y, Han X, Zhou T, Xiao C, Shi C, Wei X, Wu H. PMID: 40165325 [PubMed - indexed for MEDLINE]
	Gd-EOB-DTPA-enhanced MRI radiomics and deep learning models to predict microvascular invasion in hepatocellular carcinoma: a multicenter study. BMC Med Imaging Zhu Z, Wu K, Lu J, Dai S, Xu D, Fang W, Yu Y, Gu W. PMID: 40165094 [PubMed - indexed for MEDLINE]
	Advances in radiation therapy for HCC: Integration with liver-directed treatments. Hepatol Commun Yariv O, Newman NB, Yarchoan M, Rabiee A, Wood BJ, Salem R, Hernandez JM, Bang CK, Yanagihara TK, Escorcia FE. PMID: 40163776 [PubMed - indexed for MEDLINE]
	A cost-effective predictive tool for AFP-negative focal hepatic lesions of retrospective study: enhancing clinical triage and decision-making. PeerJ Lin Y, Wang Q, Feng M, Lao J, Wu C, Luo H, Ji L, Xia Y. PMID: 40161339 [PubMed - indexed for MEDLINE]
	The role of immune regulation in HBV infection and hepatocellular carcinogenesis. Front Immunol Zheng H, Xu B, Fan Y, Tuekprakhon A, Stamataki Z, Wang F. PMID: 40160817 [PubMed - indexed for MEDLINE]
	DIAGNOSTIC CHALLENGE: COEXISTING MULTIPLE MYELOMA AND EXTRAMEDULLARY PLASMACYTOMA WITH RENAL AND HEPATIC INVOLVEMENT. Georgian Med News Tsanava K, Khurtsia L, Shengelia E, Qvariani G, Dangadze L. PMID: 40159251 [PubMed - indexed for MEDLINE]
	Prognostic value of neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma receiving curative therapies: a systematic review and meta-analysis. BMC Cancer Peng J, Chen H, Chen Z, Tan J, Wu F, Li X. PMID: 40158082 [PubMed - indexed for MEDLINE]
	Phase Ib/II trial of talimogene laherparepvec alone and with pembrolizumab in advanced solid tumors with liver metastases and hepatocellular carcinoma. Oncologist Hecht JR, Oberoi A, Garralda Cabanas E, Jae Chon H, Digklia A, Rottey S, Martin Jimenez M, Chaney M, Hippenmeyer J, Lawrence T, Liu K, Hamidi A, Chesney J. PMID: 40156118 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 71293

Seite 1 von 3565

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung